Stem Cell Sciences in new Scottish pact
Wednesday, 01 February, 2006
Stem Cell Sciences (AIM:STEM, SCS) has signed a new tech transfer agreement with the University of Edinburgh, building on a formal collaboration begun in 1994.
The new agreement supersedes the original agreement, with all previous patent licenses issued to SCS remaining with the company. SCS is also continuing its partnership with the University of Edinburgh's Institute of Stem Cell Research.
"We are pleased to have reached a new, mutually beneficial agreement that will help to accelerate the commercialisation of stem cell technologies," said SCS's Edinburgh-based CEO, Peter Mountford, in a statement.
CTA granted for CAR-T cell therapy for multiple myeloma
The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell...
2026 Snow Fellowship recipients to receive $24m in biomedical funding
Australian biomedical researchers Dr Deborah Burnett, A/Prof Sudarshini Ramanathan and Dr Ira...
$780m Sydney Biomedical Accelerator gains its founding Executive Director
Professor Victoria Cogger has been appointed as founding Executive Director of the Sydney...
